-
Mashup Score: 0
DENVER — A varied and well-balanced diet plays “a significant role” in the management of patients with inflammatory bowel disease and can be guided with support from a dietitian, a presenter reported at the Crohn’s and Colitis Congress.“IBD has long been thought to arise from inappropriate and maladaptive stimulation of the immune system, although emerging data has
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0AGA risk assessment tool aids patient, physician decision-making for Crohn’s therapy - 1 year(s) ago
DENVER — A risk stratification assessment assisted both patients with Crohn’s disease and their physicians when making decisions about treatment, according to data presented at the Crohn’s and Colitis Congress. Earlier introduction of advanced therapy may improve longer-term clinical outcomes in CD, with current clinical guidelines recommending the incorporation of risk
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0‘Keep our hands on the wheel’: Caution, supervision urged as AI enters the IBD space - 1 year(s) ago
DENVER — Although the use of artificial intelligence for inflammatory bowel disease can reasonably replicate expert judgment and predict outcomes, clinicians must retain the ability to intervene and “take control” when the AI is wrong.“I don’t have to tell any of you that artificial intelligence is everywhere right now, doing some truly amazing tasks and starting to
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0‘Why not combine them?’: Early dual biologic therapy may overcome limits in severe IBD - 1 year(s) ago
DENVER — Early data suggest combination therapy with biologics or advanced small-molecules may be safe and effective in patients with inflammatory bowel disease, according to a presenter at the Crohn’s and Colitis Congress.“We have all these different mechanisms of action right now — in newer development are some of the oral and p-19 [inhibitors],” Edward V. Loftus
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 2VIDEO: 'Deep understanding’ of epidemiology, biology needed to achieve cure, prevent IBD - 1 year(s) ago
DENVER — In a Healio video exclusive, James D. Lewis, MD, MSCE, a gastroenterologist at the University of Pennsylvania Perelman School of Medicine, discusses what it might take to eventually cure or prevent inflammatory bowel disease.According to Lewis, there has been “incredible” progress in IBD management over the past several decades with the expansion of new biologic
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 1
DENVER — Hyperbaric oxygen therapy yielded a clinical response rate of 87% among patients with fistulizing Crohn’s disease with few adverse events, according to systematic review data presented at the Crohn’s and Colitis Congress.“Fistulas are a common complication of Crohn’s disease occurring in up to 50% of patients,” Amr Dokmak, MD, a hospitalist at Catholic
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0
The 12-24 session counseling program also resulted in improvements in sleep quality, fatigue level, and stress levels for patients with inflammatory bowel disease.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0‘Why not combine them?’: Early dual biologic therapy may overcome limits in severe IBD - 1 year(s) ago
DENVER — Early data suggest combination therapy with biologics or advanced small-molecules may be safe and effective in patients with inflammatory bowel disease, according to a presenter at the Crohn’s and Colitis Congress.“We have all these different mechanisms of action right now — in newer development are some of the oral and p-19 [inhibitors],” Edward V. Loftus
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0
DENVER — Socioeconomic status, household composition and housing or transportation were among predictors of low vaccination rates in patients with inflammatory bowel disease, according to a presenter at the Crohn’s and Colitis Congress. “Despite an increased risk for infection, patients with IBD have low vaccination rates,” Jessica Sheehan, MD, a gastroenterology and
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0
There is not much data available on the interaction between Paxlovid and tacrolimus.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet
#ICYMI: “We should encourage our #patients to consume a varied and well-balanced #diet," Keisa M. Lynch, DNP, APRN, FNP, said at #CCCongress23. #GITwitter #MedTwitter #IBD https://t.co/5deHfGU1Lv